Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Preferred Dividend Payments (2016 - 2025)

Cardiff Oncology's Preferred Dividend Payments history spans 15 years, with the latest figure at $7000.0 for Q4 2025.

  • For Q4 2025, Preferred Dividend Payments rose 16.67% year-over-year to $7000.0; the TTM value through Dec 2025 reached $25000.0, up 4.17%, while the annual FY2025 figure was $25000.0, 4.17% up from the prior year.
  • Preferred Dividend Payments for Q4 2025 was $7000.0 at Cardiff Oncology, up from $6000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $7000.0 in Q4 2025 and bottomed at $6000.0 in Q1 2021.
  • The 5-year median for Preferred Dividend Payments is $6000.0 (2021), against an average of $6050.0.
  • The largest annual shift saw Preferred Dividend Payments fell 0.99% in 2021 before it increased 16.67% in 2025.
  • A 5-year view of Preferred Dividend Payments shows it stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then increased by 16.67% to $7000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Preferred Dividend Payments are $7000.0 (Q4 2025), $6000.0 (Q3 2025), and $6000.0 (Q2 2025).